April 17, 2026 1:52 pm

Author: Share IBD Movement

New IBD Drug Shows Promise for Crohn’s and UC Patients

New clinical trial results for duvakitug show promising effectiveness for both Crohn’s disease and ulcerative colitis, offering hope for patients seeking better treatment options. This novel drug targets inflammation and scarring through a different mechanism than existing treatments, potentially expanding the toolkit for IBD management.

New Crohn’s Treatment Shows Promise for Real Healing

AstraZeneca’s new experimental drug AZD7798 takes a precision approach to Crohn’s treatment, targeting specific immune cells while aiming for actual intestinal healing rather than just symptom management. This targeted therapy could represent a significant shift toward treatments that address root causes and offer more stable, long-term remission.

You Missed

Vitamin D Shows Promise for Resetting Immune Response in IBD: What This Could Mean for Your Treatment

Vitamin D Shows Promise for Resetting Immune Response in IBD: What This Could Mean for Your Treatment

April 12, 2026
Low-FODMAP Diet for Crohn's Disease: Managing Symptoms Without Treating Inflammation

Low-FODMAP Diet for Crohn’s Disease: Managing Symptoms Without Treating Inflammation

April 11, 2026
New Research Reveals Promising Results for Fecal Microbiota Transplantation in IBD Treatment

New Research Reveals Promising Results for Fecal Microbiota Transplantation in IBD Treatment

April 10, 2026
Is My Extreme Fatigue From IBD or Something Else? Understanding the Complex Causes of Exhaustion

Is My Extreme Fatigue From IBD or Something Else? Understanding the Complex Causes of Exhaustion

April 10, 2026